![](https://investorshub.advfn.com/uicon/756666.png?cb=1598094430)
Thursday, October 15, 2020 3:40:49 PM
The title is...
Relief Therapeutics (OTC:RLFTF): NeuroRx to list on NYSE via Merger
Which to me looks like this is an update about RLFTF stock for RLFTF investors, and that update is... their partner (Neuro) is seeking to list on NYSE via a merger approach.
That's why there is a colon (:) after Relief Therapeutics.
And then... in the article, it states...
"NeuroRx a company who is partnered with promising COVID-19 therapeutic maker Relief Therapeutics (OTC: RLFTF) has decided to merge and list with a NYSE company (3-6 months)."
So... the way the sentence is structured, someone could misunderstand that the merge is between Relief and Neuro, but in fact, the rest of the sentence says "merge and list with a NYSE company".
So... look at the article as an update for RLFTF investors... that's what I think it was intended to do.
But yeah... although the title is technically done right, it inadvertently comes across a bit misleading.
Disclaimer: I am not a professional advisor. Seek professional advice before investing or trading. I take risky positions and do not advise anyone to follow my opinions or actions.
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM